Carson Wealth (CWM LLC)’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.91M Sell
62,328
-5,052
-7% -$352K 0.01% 913
2025
Q4
$4.47M Sell
67,380
-91,609
-58% -$5.92M 0.01% 832
2025
Q3
$10.7M Sell
158,989
-4,293
-3% -$340K 0.03% 448
2025
Q2
$14.3M Sell
163,282
-2,862
-2% -$224K 0.05% 310
2025
Q1
$11.3M Buy
166,144
+3,897
+2% +$318K 0.05% 324
2024
Q4
$12.6M Buy
162,247
+42,211
+35% +$3.13M 0.05% 274
2024
Q3
$8.05M Sell
120,036
-20,301
-14% -$1.67M 0.03% 351
2024
Q2
$15.9M Sell
140,337
-5,529
-4% -$699K 0.08% 232
2024
Q1
$20.2M Sell
145,866
-2,303
-2% -$289K 0.1% 198
2023
Q4
$18.4M Buy
148,169
+1,976
+1% +$202K 0.1% 196
2023
Q3
$13.6M Buy
146,193
+140,633
+2,529% +$15.9M 0.08% 199
2023
Q2
$715K Buy
5,560
+551
+11% +$66.6K ﹤0.01% 827
2023
Q1
$582K Buy
5,009
+363
+8% +$40.6K ﹤0.01% 841
2022
Q4
$526K Buy
4,646
+633
+16% +$69.5K ﹤0.01% 791
2022
Q3
$323K Buy
4,013
+1,212
+43% +$103K ﹤0.01% 886
2022
Q2
$209K Buy
2,801
+757
+37% +$69.1K ﹤0.01% 1032
2022
Q1
$261K Buy
2,044
+904
+79% +$98.9K ﹤0.01% 937
2021
Q4
$153K Buy
+1,140
New +$164K ﹤0.01% 1133
2021
Q2
$38K Hold
360
﹤0.01% 1515
2021
Q1
$38K Hold
360
﹤0.01% 1515
2020
Q4
$38K Hold
360
﹤0.01% 1515
2020
Q3
$38K Hold
360
﹤0.01% 1515
2020
Q2
$38K Hold
360
﹤0.01% 1513
2020
Q1
$38K Hold
360
﹤0.01% 1513
2019
Q4
$38K Hold
360
﹤0.01% 1513
2019
Q3
$38K Hold
360
﹤0.01% 1513
2019
Q2
$38K Hold
360
﹤0.01% 1513
2019
Q1
$38K Sell
360
-130,320
-100% -$4.58M ﹤0.01% 1513
2018
Q4
$3.91M Buy
130,680
+26,816
+26% +$851K 0.1% 180
2018
Q3
$3.71M Sell
103,864
-37,020
-26% -$1.15M 0.09% 193
2018
Q2
$3.35M Sell
140,884
-71,368
-34% -$1.51M 0.11% 156
2018
Q1
$3.94M Sell
212,252
-8,228
-4% -$122K 0.16% 115
2017
Q4
$3.16M Buy
220,480
+120,696
+121% +$1.57M 0.14% 123
2017
Q3
$1.22M Buy
+99,784
New +$1.76M 0.06% 189

Other funds holding DXCM

Carson Wealth (CWM LLC)'s DXCM Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its DexCom (DXCM) stake by 7.5% in Q1 2026, selling an estimated $352K and leaving 62,328 shares worth $3.91M. The position accounts for 0.01% of the portfolio, ranked #913.

Carson Wealth (CWM LLC) first reported a position in DXCM in Q3 2017 and has held it in 34 quarters since. The position peaked at $20.2M in Q1 2024. 960 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Carson Wealth (CWM LLC) held 62,328 shares of DexCom worth $3.91M as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 5,052 DexCom shares in Q1 2026, an estimated $352K.
  • DexCom made up 0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #913 holding.
  • Carson Wealth (CWM LLC) first reported a position in DexCom in Q3 2017 and has held it in 34 quarters since.
  • Carson Wealth (CWM LLC)'s DexCom position peaked at $20.2M in Q1 2024.
  • 960 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.